Clinical Trial Update: Aliskiren and Renin Inhibition in Diastolic Heart Failure [NA]

View source ↗

Summary

A clinical trial evaluating aliskiren, a renin inhibitor, for heart failure with preserved ejection fraction (diastolic heart failure) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Aliskiren (Aliskiren)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Diastolic Heart Failure | NA | Status: WITHDRAWN